About the Breast Cancer Research Foundation
The Breast Cancer Research Foundation (BCRF) is dedicated to being the end of breast cancer by advancing the world's most promising research. Founded by Evelyn H. Lauder in 1993, BCRF-funded investigators have been deeply involved in every major breakthrough in breast cancer prevention, diagnosis, treatment and survivorship.
In 2021-2022, BCRF awarded $47.5 million in annual grants to 250 scientists from top universities and medical institutions around the globe. In addition, BCRF has established the Evelyn H. Lauder Founder’s Fund, a multi-year international program dedicated to metastasis that is the first large-scale global effort to unravel the biology of metastasis, with $31 million earmarked to date. It is the largest privately funded project exclusively focused on metastasis in the world.